Rick Farris serves as a board member of REV Clinical, bringing more than three decades of leadership experience across the life sciences industry, with deep expertise in clinical research, drug development, and global CRO operations. Most recently, he served as Managing Director, North America at Novotech, where he played a key role in leading North American operations and driving organizational growth. Throughout his career, Rick has held senior leadership positions across global CRO organizations, overseeing global project management, business development, client relationships, consulting, and operational strategy. His extensive experience partnering with biotech companies has supported the development and advancement of innovative therapies across multiple therapeutic areas. At REV Clinical, Rick brings valuable strategic insight as the organization continues to expand its global capabilities and strengthen its position as a specialized clinical development partner to emerging and mid-sized biotech companies.